Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of SRT2104 in Type 2 Diabetes Mellitus
2009-010720-26Phase 2Completed
- Sponsor
- Sirtris Pharmaceuticals
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SRT2104 in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Sirtris Pharmaceuticals. Primary endpoint: Pharmacokinetics of SRT2104. Started Apr 2009; status: completed.
02
Drugs
SRT2104
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-010720-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010720-26.